AbCellera Biologics Stock Jumps 15% to New 52-Week High on Hot Flash Drug Momentum and Price Target Hike

Source: Ibtimes.com.au· Jerry Thompson· August 25, 2026
AbCellera Biologics Stock Jumps 15% to New 52-Week High on Hot Flash Drug Momentum and Price Target Hike

AbCellera Biologics' stock surged after positive Phase 2 trial results for its menopause drug, ABCL635. The company's market value increased significantly, driven by investor enthusiasm and analyst upgrades.

This story was reported by Ibtimes.com.au. Read the full original article:
Read on Ibtimes.com.au

More in Business & Funding

View all